ResearcherColumbia University Irving Medical CenterNo recent work listed

Yan Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2041-3115; OpenAlex author ID A5100511705. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Co-author DOI 10.1038/s41388-021-02040-9 ↗
HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Co-author DOI 10.1016/j.canlet.2018.11.007 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yi Miao · 2 shared papers, 2019–2021 · strength 0.20
- Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9 ↗
- Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007 ↗
Wanglong Qiu · 2 shared papers, 2019–2021 · strength 0.20
- Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9 ↗
- Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007 ↗
Gloria Huei-Ting Su · 2 shared papers, 2019–2021 · strength 0.20
- Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9 ↗
- Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007 ↗
Haoqiang Ying · 1 shared paper, 2021 · strength 0.11
- Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9 ↗
Ji Luo · 1 shared paper, 2021 · strength 0.11
- Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9 ↗
Yunpeng Peng · 1 shared paper, 2019 · strength 0.09
- Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007 ↗
Chunhua Xi · 1 shared paper, 2019 · strength 0.09
- Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007 ↗
Jishu Wei · 1 shared paper, 2019 · strength 0.09
- Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007 ↗
Min Tu · 1 shared paper, 2019 · strength 0.09
- Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.